Short answer: Search the trial number in the original registry, open the full record, and check its recruitment status, last update, and participating locations. If it says Recruiting, contact the listed study team to confirm that your chosen site is accepting people for screening. The label describes recruitment, not whether you qualify or have a place in the study.
Use ClinicalTrials.gov for an NCT number and jRCT for a jRCT number. These registries provide study records; neither a listing nor a recruitment label establishes that the intervention is effective. Clinicaltrials.gov Jrct.mhlw.go.jp

Find the original trial record
Copy the registration number from the hospital page or study information sheet. Check that the record’s title, condition, intervention, and sponsor match the study you mean. If you have no number, search by the condition and intervention, then compare those details before contacting anyone.
- ClinicalTrials.gov is run by the US National Library of Medicine and includes studies conducted outside the United States. An NCT number identifies a record in this registry. Clinicaltrials.gov
- jRCT holds Japanese clinical research records. Use the current jrct.mhlw.go.jp address rather than an old bookmark. Jrct.mhlw.go.jp
- UMIN-CTR is another Japanese registry, operated by the University Hospital Medical Information Network. Ctr
- The MHLW JPRN Search Portal lets you search jRCT and UMIN-CTR together. Open the underlying registry record to check its dates and recruitment information. En
- WHO ICTRP can help you locate registrations across registries. If you find several records for one study, compare the identifiers and ask the study team about conflicting information. Clinical trials registry platform
Read the recruitment status
The table below summarizes ClinicalTrials.gov status labels. Other registries use different wording and categories; for example, jRCT’s English search includes Pending and Recruiting. Do not assume that every label has an exact equivalent across registries. Study data structure Search?language=en
| ClinicalTrials.gov status | What to do |
|---|---|
| Recruiting | The study reports that it is seeking participants. Check your location and ask whether screening is open there. |
| Not yet recruiting | Recruitment has not started. Ask about the expected opening date; a planned study start is not confirmation that screening is available. |
| Enrolling by invitation | Participants are selected from a defined group. Ask whether an invitation or prior participation is required. |
| Active, not recruiting | The study is continuing but is not recruiting new participants. Ongoing treatment or follow-up does not mean new places are available. |
| Suspended | The study has stopped temporarily and may resume. Ask about its current position rather than arranging a screening visit. |
| Terminated | The study stopped early and will not resume. Read the stated reason; the label alone does not explain the findings. |
| Withdrawn | The study stopped before enrolling its first participant. |
| Completed | The study ended normally. It is not an opportunity for new enrollment; results may not yet be available. |
| Unknown | The recruitment information has not been confirmed within the registry’s required timeframe. Do not interpret it as Recruiting; ask the listed team for clarification. |
Check your site and the record’s dates
Separate study status from site status
A multicenter trial can be Recruiting overall while one location is not recruiting. In the locations section, find the specific hospital you could attend and check any site-level recruitment information. ClinicalTrials.gov stores overall and location-level status separately. If the site status is missing, ask the study team rather than assuming the hospital is open to applicants. Study data structure
A general list of stem cell hospitals in Japan cannot establish which hospitals participate in a particular trial. Match the hospital against that trial’s own record.
Read dates as context, not a guarantee
Look at the last update or verification date alongside the study start and completion dates. A recent update does not guarantee that a place is available, and an older record is a reason to seek confirmation—not proof that the study has closed. An estimated completion date is not a recruitment deadline.
For Japanese studies, the study period and recruitment period are not necessarily the same. Read the detailed record and any hospital enrollment notice rather than using the study end date to decide whether you can apply. CL_202303_jRCT_mikata
Ask the study team whether screening is open
Use the contact listed in the registry or the participating hospital’s official trial page. Check the hospital’s inquiry and referral instructions before writing. The jRCT reading guide explains how to find recruitment, eligibility, institution, and contact information. CL_202303_jRCT_mikata
Start with the trial number, hospital name, and a question about screening. Avoid sending medical records through an unverified email address or a general marketing form. You can use this wording:
I am asking about trial [trial number] at [hospital]. Is this site currently accepting people for screening? Do I need a doctor’s referral? Please let me know the next step and the secure way to provide any medical information you require.
A reply inviting you to screening is not acceptance into the trial. The team still needs to check the inclusion and exclusion criteria. Prepare your diagnosis, disease stage where relevant, and prior-treatment information with your own clinician; NCI’s search guidance recommends reviewing potential matches with your provider. Help
Ask about visit frequency, follow-up, language support, and residence requirements before making travel plans. A medical travel guide for Japan can help with general logistics, but the study team determines the trial’s visit schedule and enrollment process.
Work through conflicting information
Illustrative scenario: the registry says Recruiting, but your hospital’s page says applications are closed. This is not a patient case or a report of a particular trial. It shows why overall recruitment and local availability must be checked separately.
Record the trial number, both page URLs, their displayed dates, and the date you checked them. Send the discrepancy to the listed trial contact and ask whether screening is open at that hospital. Until you have an answer, treat local availability as unconfirmed—not as acceptance or a definite rejection.
If no one replies, try the hospital’s clinical trial office using its official contact details. If you need help identifying the correct department, check the hospital’s referral process alongside the administrative points in choosing a stem cell hospital in Japan. Do not book travel solely because a search snippet or registry label says Recruiting.
Distinguish trial enrollment from treatment advertising
An appointment offer is not evidence of trial recruitment. Ask for the registry number, study protocol information, participating institution, and research consent process. The documents described in a private treatment process in Japan are not a substitute for confirming enrollment in a named study.
Payment alone does not tell you whether something is a trial. NCI explains that US cancer trial participants may face routine-care and other out-of-pocket costs; coverage depends on the study and the person’s circumstances. That guidance does not establish coverage for a Japanese stem cell study. Ask its team which research, routine-care, travel, and follow-up costs you would pay. Paying
Keep approved treatment, an experimental intervention in a study, and a private clinic’s service separate when reading a regenerative medicine overview. FDA’s US consumer guidance warns that registering a regenerative medicine study does not mean its product is legally marketed or approved. Important patient and consumer information about regenerative medicine therapies
In Japan, filing a regenerative medicine provision plan is not the same as obtaining product approval, and it does not establish that a clinical trial is recruiting or that the intervention works. Japan’s regulatory framework must be considered separately from US approval rules. Index
Need help understanding a Japanese hospital page?
Ask about language or administrative support. Recruitment, eligibility, and acceptance must be confirmed by the trial team; this inquiry is not an application to a study.
Bottom line: Check the original record, your chosen site, and the update dates, then ask the listed team whether screening is open. Recruiting is an invitation to inquire—not a promise of eligibility, a reserved place, or evidence of benefit. Discuss participation with your own clinician. This article provides general information, not personal medical advice.




